AGL 39.15 Decreased By ▼ -0.85 (-2.13%)
AIRLINK 127.50 Decreased By ▼ -1.56 (-1.21%)
BOP 6.77 Increased By ▲ 0.02 (0.3%)
CNERGY 4.66 Increased By ▲ 0.17 (3.79%)
DCL 8.46 Decreased By ▼ -0.09 (-1.05%)
DFML 41.10 Increased By ▲ 0.28 (0.69%)
DGKC 82.00 Increased By ▲ 1.04 (1.28%)
FCCL 33.01 Increased By ▲ 0.24 (0.73%)
FFBL 73.40 Decreased By ▼ -1.03 (-1.38%)
FFL 11.77 Increased By ▲ 0.03 (0.26%)
HUBC 109.35 Decreased By ▼ -0.23 (-0.21%)
HUMNL 14.25 Increased By ▲ 0.50 (3.64%)
KEL 5.22 Decreased By ▼ -0.09 (-1.69%)
KOSM 7.60 Decreased By ▼ -0.12 (-1.55%)
MLCF 39.09 Increased By ▲ 0.49 (1.27%)
NBP 63.50 Decreased By ▼ -0.01 (-0.02%)
OGDC 192.50 Decreased By ▼ -2.19 (-1.12%)
PAEL 25.70 Decreased By ▼ -0.01 (-0.04%)
PIBTL 7.31 Decreased By ▼ -0.08 (-1.08%)
PPL 153.50 Decreased By ▼ -1.95 (-1.25%)
PRL 25.35 Decreased By ▼ -0.44 (-1.71%)
PTC 17.30 Decreased By ▼ -0.20 (-1.14%)
SEARL 78.15 Decreased By ▼ -0.50 (-0.64%)
TELE 7.56 Decreased By ▼ -0.30 (-3.82%)
TOMCL 33.29 Decreased By ▼ -0.44 (-1.3%)
TPLP 8.40 No Change ▼ 0.00 (0%)
TREET 16.10 Decreased By ▼ -0.17 (-1.04%)
TRG 56.70 Decreased By ▼ -1.52 (-2.61%)
UNITY 27.45 Decreased By ▼ -0.04 (-0.15%)
WTL 1.36 Decreased By ▼ -0.03 (-2.16%)
BR100 10,476 Increased By 30.5 (0.29%)
BR30 31,021 Decreased By -168.2 (-0.54%)
KSE100 97,917 Increased By 118.9 (0.12%)
KSE30 30,532 Increased By 51.2 (0.17%)
Business & Finance

CureVac says interest in its COVID-19 vaccine on the rise

  • The European Union in November secured up to 405 million doses of CureVac's two-shot vaccine, which has yet to win regulatory approval, the company's only large supply contract so far.
  • Europe's choppy vaccine rollout hit more trouble this week after J&J suspended shipments of its COVID-19 shot and Denmark said it would drop a similar vaccine from AstraZeneca over very rare cases of blood clotting.
Published April 15, 2021

FRANKFURT: German biotech firm CureVac said it had seen the number of requests for its experimental COVID-19 vaccine increase over the past few days, following a halt of the use of Johnson & Johnson's shot amid concerns over rare side effects.

The European Union in November secured up to 405 million doses of CureVac's two-shot vaccine, which has yet to win regulatory approval, the company's only large supply contract so far.

A spokesman said requests have been coming in from various actors, including governments and international organisations but he declined to elaborate. The group is to hold an analyst call on fourth-quarter results at 1400 GMT.

Europe's choppy vaccine rollout hit more trouble this week after J&J suspended shipments of its COVID-19 shot and Denmark said it would drop a similar vaccine from AstraZeneca over very rare cases of blood clotting.

Comments

Comments are closed.